Varian Medical Systems, Inc.

Palo Alto, California

Classification

Private

About

About

Varian Medical Systems, Inc. is a company in the field of oncology and radiation therapy. For over 75 years, Varian has been dedicated to developing and providing advanced solutions for cancer treatment and care. They offer a comprehensive range of innovative technologies, software, and services aimed at enhancing cancer treatment efficiency, accuracy, and patient outcomes. Product/Service Line Breakdown: Oncology Solutions: Advanced radiotherapy and oncology systems for cancer treatment. Radiosurgery Systems: High-precision systems for radiosurgery procedures. Proton Therapy Systems: Specialized equipment for proton therapy, targeting tumors with precision. Brachytherapy Systems: Solutions for internal radiation therapy for various cancers. Software and AI Solutions: Innovative software and AI-driven tools for treatment planning, monitoring, and analysis in oncology.

Financials

Revenue & Profit

Revenue

Valuation

Valuation

Ratios

Revenue / EBITDA
$123 MM
Valuation / Revenue
$123 MM
Valuation / Employees
$123 MM
EBITDA / Revenue
$123 MM
1-Year CAGR (Revenue)
03
3-Year CAGR (Revenue)
11
1-Year CAGR (Employees)
19
3-Year CAGR (Employees)
96

People

Employee Figures

Employees

Key Executives

NameTitleSocialsEmailPhone
John DoeEmployee
--
Jane DoeEmployee
John DoeEmployee
John DoeEmployee

401K

Total Active Participants
1234
No. Participants with Account Balances
56789
Total Liabilities Start of Year
1234
Total Assets Start of Year
56789

Deals

M&A2024-03-15Completed

Seller

Founders Group

Investor Sponsors

NorthBridge PE

Deal Amount

$120M

Target Company Valuation

$1.20 MM

Techniques

Acquisition of Assets, Taken Private

Stake Tags

100%

Is PE deal

Yes

Is deal PE backed

Yes

Total Acquired

100%

Secondary Transaction2023-09-01Canceled

Target

BrightHealth Technologies

Seller

Early Investors Consortium

Investor Sponsors

--

Deal Amount

Undisclosed

Target Company Valuation

NaN

Techniques

Secondary Sale, Management Buy-out (MBO)

Stake Tags

Majority

Is PE deal

No

Is deal PE backed

Yes

Total Acquired

65%

Funding

Keywords

Keywords

Classified

Private